64 related articles for article (PubMed ID: 9135629)
1. Reasons given by patients for "non-progression' in HIV infection.
Troop M; Easterbrook P; Thornton S; Flynn R; Gazzard B; Catalan J
AIDS Care; 1997 Apr; 9(2):133-42. PubMed ID: 9135629
[TBL] [Abstract][Full Text] [Related]
2. The characterization of non-progressors: long-term HIV-1 infection with stable CD4+ T-cell levels.
Sheppard HW; Lang W; Ascher MS; Vittinghoff E; Winkelstein W
AIDS; 1993 Sep; 7(9):1159-66. PubMed ID: 8105806
[TBL] [Abstract][Full Text] [Related]
3. [Socio-demographic and life-style factors in a Swiss study of HIV non-progression].
Kopp C; Lang S; von Overbeck J
Schweiz Med Wochenschr; 1999 Oct; 129(39):1397-404. PubMed ID: 10542997
[TBL] [Abstract][Full Text] [Related]
4. Low postseroconversion CD4 count and rapid decrease of CD4 density identify HIV+ fast progressors.
Audigé A; Taffé P; Rickenbach M; Battegay M; Vernazza P; Nadal D; Speck RF;
AIDS Res Hum Retroviruses; 2010 Sep; 26(9):997-1005. PubMed ID: 20715931
[TBL] [Abstract][Full Text] [Related]
5. Detection of human herpesvirus 7 DNA in peripheral blood reflects mainly CD4+ cell count in patients infected with HIV.
Boutolleau D; Bonduelle O; Sabard A; Devers L; Agut H; Gautheret-Dejean A;
J Med Virol; 2005 Jun; 76(2):223-8. PubMed ID: 15834866
[TBL] [Abstract][Full Text] [Related]
6. [Natural history of human immunodeficiency virus infection in a cohort of Chilean patients].
Vial PA; Ferreccio C; Abarca K; Ortiz E; Noriega M; Pérez C; Labarca J; Torres M; Ferrés M; González C; Acuña G
Rev Med Chil; 1996 May; 124(5):525-35. PubMed ID: 9035503
[TBL] [Abstract][Full Text] [Related]
7. The HLA-B*5703 allele confers susceptibility to the development of spondylarthropathies in Zambian human immunodeficiency virus-infected patients with slow progression to acquired immunodeficiency syndrome.
López-Larrea C; Njobvu PD; González S; Blanco-Gelaz MA; Martínez-Borra J; López-Vázquez A
Arthritis Rheum; 2005 Jan; 52(1):275-9. PubMed ID: 15641063
[TBL] [Abstract][Full Text] [Related]
8. Human immunodeficiency virus type 1 long-term non-progressors: the viral, genetic and immunological basis for disease non-progression.
Poropatich K; Sullivan DJ
J Gen Virol; 2011 Feb; 92(Pt 2):247-68. PubMed ID: 21106806
[TBL] [Abstract][Full Text] [Related]
9. [Rapid and slow progression of the infection by the type 1 human immunodeficiency virus in a population of seropositive subjects in Madrid].
Soriano V; Martín R; del Romero J; Castilla J; Bru F; Bravo R; Gutiérrez M; Martínez P; Valencia E; García S; Mas A; Moreno V; Laguna F; Rodríguez C; Sabín ML; González-Lahoz J
Med Clin (Barc); 1996 Dec; 107(20):761-6. PubMed ID: 9019602
[TBL] [Abstract][Full Text] [Related]
10. Association between AIDS disease progression rates and the Fok-I polymorphism of the VDR gene in a cohort of HIV-1 seropositive patients.
Nieto G; Barber Y; Rubio MC; Rubio M; Fibla J
J Steroid Biochem Mol Biol; 2004 May; 89-90(1-5):199-207. PubMed ID: 15225772
[TBL] [Abstract][Full Text] [Related]
11. Long-term survival without clinical AIDS after CD4+ cell counts fall below 200 x 10(6)/l.
Hoover DR; Rinaldo C; He Y; Phair J; Fahey J; Graham NM
AIDS; 1995 Feb; 9(2):145-52. PubMed ID: 7718184
[TBL] [Abstract][Full Text] [Related]
12. The natural history of human immunodeficiency virus infection among adults in Mumbai.
Hira SK; Shroff HJ; Lanjewar DN; Dholkia YN; Bhatia VP; Dupont HL
Natl Med J India; 2003; 16(3):126-31. PubMed ID: 12929853
[TBL] [Abstract][Full Text] [Related]
13. Assessment of human cytomegalovirus specific T cell immunity in human immunodeficiency virus infected patients in different disease stages following HAART and in long-term non-progressors.
Tamarit A; Alberola J; Mira JV; Tornero C; Galindo MJ; Navarro D
J Med Virol; 2004 Nov; 74(3):382-9. PubMed ID: 15368523
[TBL] [Abstract][Full Text] [Related]
14. Neutralization and enhancement of HIV-1 infection by sera from HIV-1 infected individuals who progress to disease at different rates.
Jolly PE; Weiss HL
Virology; 2000 Jul; 273(1):52-9. PubMed ID: 10891407
[TBL] [Abstract][Full Text] [Related]
15. [Frequency and characteristics of patients treated with zidovudine and absence of progression of HIV infection].
Soriano V; Heredia A; Mas A; Vallejo A; Garćia-Lerma G; Bravo R; Gómez-Cano M; Villalba N; Moreno V; Laguna F; Valencia E; Martínez P; González-Lahoz J
An Med Interna; 1997 Jun; 14(6):282-5. PubMed ID: 9410098
[TBL] [Abstract][Full Text] [Related]
16. Nef alleles from children with non-progressive HIV-1 infection modulate MHC-II expression more efficiently than those from rapid progressors.
Schindler M; Wildum S; Casartelli N; Doria M; Kirchhoff F
AIDS; 2007 May; 21(9):1103-7. PubMed ID: 17502720
[TBL] [Abstract][Full Text] [Related]
17. [Genetic determinant factors of resistance to HIV infection and of control of progression to AIDS: implications on pathogenesis and therapeutic approaches for the eradication of HIV. A review].
Zúñiga J; Vargas-Alarcón G; Salgado N; Flores C; Martínez-Tripp S; Miranda A; Balbuena A; Osnaya N; Juárez F; Granados J; Reyes-Terán G
Rev Invest Clin; 2000; 52(3):284-95. PubMed ID: 10953612
[TBL] [Abstract][Full Text] [Related]
18. Characterization of GBV-C infection in HIV-1 infected patients.
Canducci F; Uberti Foppa C; Boeri E; Racca S; Gallotta G; Grasso MA; Calori G; Lazzarin A; Clementi M
J Biol Regul Homeost Agents; 2003; 17(2):191-4. PubMed ID: 14518722
[TBL] [Abstract][Full Text] [Related]
19. [An ambispective cohort study of the natural history of HIV infection among former unsafe commercial blood and plasma donors].
Zhang FJ; Dou ZH; Yu L; Ma Y; Wang N; Cao GH; Li CT; Zhao JX; Meng XD; Qiao XC; Huo W; Zhao HX; Liu ZF; Wang L; Shang H
Zhonghua Liu Xing Bing Xue Za Zhi; 2008 Jan; 29(1):9-12. PubMed ID: 18785469
[TBL] [Abstract][Full Text] [Related]
20. Immunologic markers of AIDS progression: consistency across five HIV-infected cohorts. Multicohort Analysis Project Workshop. Part I.
AIDS; 1994 Jul; 8(7):911-21. PubMed ID: 7946100
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
